Management of hidradenitis suppurativa in the inpatient setting: a clinical guide

Hidradenitis suppurativa (HS) is a chronic inflammatory disease that affects the axilla, inframammary folds, buttocks, inner thighs, and anogenital regions. Patients with moderate to severe HS often seek care in the emergency department and may require hospitalization; however, the lack of clear adm...

Full description

Saved in:
Bibliographic Details
Published in:Archives of Dermatological Research 2025-01, Vol.317 (1), p.202, Article 202
Main Authors: Maskan Bermudez, Narges, Elman, Scott A., Kirsner, Robert S., Lev-Tov, Hadar
Format: Article
Language:English
Subjects:
Anogenital
Dermatology
Disease management
Emergency medical care
Hidradenitis Suppurativa - diagnosis
Hidradenitis Suppurativa - therapy
Hospitalization
Humans
Inflammatory diseases
Medicine
Medicine & Public Health
Pain Management - methods
Pain Management - standards
Patients
Remission
Review
Severity of Illness Index
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Hidradenitis suppurativa (HS) is a chronic inflammatory disease that affects the axilla, inframammary folds, buttocks, inner thighs, and anogenital regions. Patients with moderate to severe HS often seek care in the emergency department and may require hospitalization; however, the lack of clear admission criteria and management guidelines presents significant challenges. To address these issues, we conducted a clinical review aimed at hospitalists and consulting dermatologists considering hospital admission for patients experiencing severe HS flares. Admission offers a unique opportunity to optimize care through specialized consultations, pain management, rescue therapy, and surgical planning. Furthermore, multimodal treatments, particularly biologics, are needed to achieve clinical remission in severe disease. Streamlining care during hospitalization for the early initiation of these therapies can significantly improve flare management and overall clinical outcomes for HS patients. This review aims to improve care for HS by providing clear and comprehensive guidance on its management in the inpatient setting.
ISSN:1432-069X
0340-3696
1432-069X
DOI:10.1007/s00403-024-03622-9